MedTrace Logo

Quality of Life in RECTal Cancer - a Prospective Multicenter Cohort Study

NCT01477229 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2023-12-08

No results posted yet for this study

Summary

Rectal cancer is a common type of cancer occuring more frequently in men but also common in women. Almost 60% of the patients survive 5-years and the treatment has been continuously developed in the last three decades. The aim of the QoLiRECT study is to increase the knowledge about symptoms, functional impairments, quality of life (QoL) and psychological and socioeconomic burden in an unselected population of rectal cancer patients.

Conditions

Sponsors & Collaborators

  • Swedish Cancer Foundation

    collaborator OTHER

  • The Swedish Society of Medicine

    collaborator OTHER

  • Assar Gabrielsson Foundation

    collaborator UNKNOWN

  • Sahlgrenska University Hospital

    lead OTHER

Principal Investigators

  • Eva Angenete, M.D., Ph.D. · SSORG - Scandinavian Surgical Outcomes Research Group and Sahlgrenska University Hospital in collaboration with Sahlgrenska Academy at University of Gothenburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2015-09-30
Completion
2025-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01477229 on ClinicalTrials.gov